Corrigendum to Targeting apoptotic pathways for cancer therapy.
作者信息
Tian Xiaobing, Srinivasan Praveen R, Tajiknia Vida, Sanchez Sevilla Uruchurtu Ashley F, Seyhan Attila A, Carneiro Benedito A, De La Cruz Arielle, Pinho-Schwermann Maximilian, George Andrew, Zhao Shuai, Strandberg Jillian, Di Cristofano Francesca, Zhang Shengliang, Zhou Lanlan, Raufi Alexander G, Navaraj Arunasalam, Zhang Yiqun, Verovkina Nataliia, Ghandali Maryam, Ryspayeva Dinara, El-Deiry Wafik S
出版信息
J Clin Invest. 2025 Jul 15;135(14). doi: 10.1172/JCI196275.
Abstract
摘要
相似文献
1
Corrigendum to Targeting apoptotic pathways for cancer therapy.《靶向凋亡途径用于癌症治疗》勘误
J Clin Invest. 2025 Jul 15;135(14). doi: 10.1172/JCI196275.
2
Paclitaxel-induced mitotic arrest results in a convergence of apoptotic dependencies that can be safely exploited by BCL-X degradation to overcome cancer chemoresistance.紫杉醇诱导的有丝分裂停滞导致凋亡依赖性的汇聚，通过BCL-X降解可安全利用这种汇聚来克服癌症化疗耐药性。
bioRxiv. 2025 Jun 26:2025.06.24.661170. doi: 10.1101/2025.06.24.661170.
3
(99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.（99m）锝标记膜联蛋白A5对凋亡肿瘤反应的定量分析：临床影像学试验的系统评价和荟萃分析
Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2083-97. doi: 10.1007/s00259-015-3152-0. Epub 2015 Aug 16.
4
Light-activated multimodal nanoplatform for enhanced synergistic therapy of breast cancer.用于增强乳腺癌协同治疗的光激活多模态纳米平台。
Sci Rep. 2025 Jul 17;15(1):25995. doi: 10.1038/s41598-025-11165-w.
5
[Corrigendum] miR‑335 promotes ferroptosis by targeting ferritin heavy chain 1 in in vivo and in vitro models of Parkinson's disease.[勘误] 在帕金森病的体内和体外模型中，miR-335通过靶向铁蛋白重链1促进铁死亡。
Int J Mol Med. 2025 Aug;56(2). doi: 10.3892/ijmm.2025.5565. Epub 2025 Jun 13.
6
The interplay between autophagy and apoptosis: its implication in lung cancer and therapeutics.自噬与细胞凋亡的相互作用：在肺癌和治疗中的意义。
Cancer Lett. 2024 Mar 31;585:216662. doi: 10.1016/j.canlet.2024.216662. Epub 2024 Feb 2.
7
Beyond apoptosis: evidence of other regulated cell death pathways in the ovary throughout development and life.超越细胞凋亡：在卵巢发育和生命过程中存在其他调控细胞死亡途径的证据。
Hum Reprod Update. 2023 Jul 5;29(4):434-456. doi: 10.1093/humupd/dmad005.
8
Targeting MAP kinase for inhibiting Leishmania promastigotes and amastigotes stages by L-alanine derived molecules and their anticancer potential against PANC-1 cancer cell lines.通过L-丙氨酸衍生分子靶向丝裂原活化蛋白激酶以抑制利什曼原虫前鞭毛体和无鞭毛体阶段及其对PANC-1癌细胞系的抗癌潜力。
Bioorg Med Chem. 2025 Oct 1;128:118276. doi: 10.1016/j.bmc.2025.118276. Epub 2025 Jun 7.
9
Exosomal delivery of non-coding RNAs: a pathway to apoptosis regulation in lung cancer.外泌体介导的非编码RNA传递：肺癌细胞凋亡调控途径
Med Oncol. 2025 Jul 1;42(8):307. doi: 10.1007/s12032-025-02852-9.
10
Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence.靶向癌症干细胞以克服耐药性和肿瘤复发的纳米材料。
Front Oncol. 2025 Jun 6;15:1499283. doi: 10.3389/fonc.2025.1499283. eCollection 2025.
本文引用的文献
1
Therapeutic targeting of TRAIL death receptors.TRAIL 死亡受体的治疗靶向。
Biochem Soc Trans. 2023 Feb 27;51(1):57-70. doi: 10.1042/BST20220098.
2
A Small Molecule Reacts with the p53 Somatic Mutant Y220C to Rescue Wild-type Thermal Stability.小分子与 p53 体细胞突变 Y220C 反应以挽救野生型热稳定性。
Cancer Discov. 2023 Jan 9;13(1):56-69. doi: 10.1158/2159-8290.CD-22-0381.
3
MDM2 inhibitor APG-115 exerts potent antitumor activity and synergizes with standard-of-care agents in preclinical acute myeloid leukemia models.MDM2抑制剂APG-115在临床前急性髓系白血病模型中发挥出强大的抗肿瘤活性，并与标准治疗药物产生协同作用。
Cell Death Discov. 2021 May 3;7(1):90. doi: 10.1038/s41420-021-00465-5.
4
Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors.六价 TRAIL 融合蛋白 Eftozanermin Alfa 通过最优聚集凋亡诱导型 TRAIL 受体诱导实体瘤中的靶抗肿瘤活性。
Cancer Res. 2021 Jun 15;81(12):3402-3414. doi: 10.1158/0008-5472.CAN-20-2178. Epub 2021 Mar 9.
5
P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9.通过 ERK1/2 和 CDK9 对 ATF4 的转录调节，使突变型 p53 的肿瘤中 p53 通路部分恢复，且不依赖 p53。
Neoplasia. 2021 Mar;23(3):304-325. doi: 10.1016/j.neo.2021.01.004. Epub 2021 Feb 11.
6
Mechanisms of imipridones in targeting mitochondrial metabolism in cancer cells.米氮平类药物作用于癌细胞线粒体代谢的机制。
Neuro Oncol. 2021 Apr 12;23(4):542-556. doi: 10.1093/neuonc/noaa283.
7
The integrated stress response.整合应激反应
EMBO Rep. 2016 Oct;17(10):1374-1395. doi: 10.15252/embr.201642195. Epub 2016 Sep 14.
8
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor.在一项针对新型四价激动型纳米抗体®TAS266（靶向DR5受体）的I期研究中出现了意外的肝毒性。
Cancer Chemother Pharmacol. 2015 May;75(5):887-95. doi: 10.1007/s00280-015-2712-0. Epub 2015 Feb 27.
9
APG350 induces superior clustering of TRAIL receptors and shows therapeutic antitumor efficacy independent of cross-linking via Fcγ receptors.APG350 通过诱导 TRAIL 受体聚集，而非通过 Fcγ 受体交联，表现出优越的治疗抗肿瘤功效。
Mol Cancer Ther. 2013 Dec;12(12):2735-47. doi: 10.1158/1535-7163.MCT-13-0323. Epub 2013 Oct 7.
Zotero 插件